Literature DB >> 30646345

Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter Medications.

Jeffrey J Sutherland1, Ryan D Morrison1, Candace D McNaughton2, Thomas M Daly3, Stephen B Milne1, J Scott Daniels1, Timothy P Ryan1,4.   

Abstract

Importance: Inaccurate medication records and poor medication adherence result in incomplete knowledge of therapy for patients. Objective: To study accuracy of medical records and patient adherence by measuring blood concentrations of medications. Design, Setting, and Participants: This cross-sectional study validated a serum-based liquid chromatography-tandem mass spectrometry assay to simultaneously quantify 263 medications used for acute and chronic conditions. The assay panel was applied to 3 clinical patient cohorts: residual serum from 1000 randomly selected samples sent for routine clinical chemistry testing between April 8 and October 6, 2015 (residuals cohort), 50 prospectively enrolled patients in a gastroenterology clinic between March 1 and March 15, 2016, who were prescribed more than 5 medications (gastroenterology care cohort), and a convenience cohort of 296 patients with hypertension who sought care in an emergency department (ED care cohort) between July 1, 2012, and April 25, 2013. Integrated data analysis of the cohorts was performed from August 22 to November 29, 2017. Main Outcomes and Measures: Medication serum concentrations, electronic health record medication lists, and predicted drug interactions.
Results: Of the 1346 total samples, 1000 came from the residuals cohort (640 women and 360 men; median age, 60 years [interquartile range (IQR), 44-71 years]), 50 from the gastroenterology care cohort (30 women and 20 men; median age, 66 years [IQR, 62-70 years]), and 296 from the ED care cohort (160 women and 136 men; median age, 59 years [IQR, 52-66 years]). Median medication adherence, defined as the subset of detected medications from the prescription record, was 83% (IQR, 50%-100%) in the residuals cohort, 100% (IQR, 84%-100%) in the gastroenterology care cohort, and 78% (IQR, 57%-100%) in the ED care cohort. Patients adherent to 1 medication were more often adherent to other medications. Among patients prescribed 3 medications or more, there were no significant associations between medication adherence and sex or number of prescribed medications, and there was a modest association between adherence and age. By comparing detected vs prescribed medications, we detected a median of 0 (IQR, 0-2) medications per patient that were not listed in the electronic health record in the residuals cohort, 1 (IQR, 0-2) medication per patient that was not listed in the electronic health record in the gastroenterology care cohort, and 1 (IQR, 0-2) medication per patient that was not listed in the electronic health record in the ED care cohort. A total of 435 patients (43.5%) in the residuals cohort had no discrepancy between the electronic health record and detected medication lists, 22 patients (44.0%) in the gastroenterology care cohort had no discrepancy between the electronic health record and detected medication lists, and 41 patients (13.9%) in the ED care cohort had no discrepancy between the electronic health record and detected medication lists. Half of adverse drug reaction alerts occurred among medications detected without prescription. Conclusions and Relevance: Comprehensive medication monitoring offers promise to improve adherence, the accuracy of medical records, and the safety for patients with polypharmacy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30646345      PMCID: PMC6324396          DOI: 10.1001/jamanetworkopen.2018.4196

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


  12 in total

1.  Therapeutic drug monitoring of antidepressants and cytochrome p450 genotyping in general practice.

Authors:  Jenny E Kootstra-Ros; Marga J M Van Weelden; John W J Hinrichs; Peter A G M De Smet; Jan van der Weide
Journal:  J Clin Pharmacol       Date:  2006-11       Impact factor: 3.126

2.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.

Authors:  David W Kaufman; Judith P Kelly; Lynn Rosenberg; Theresa E Anderson; Allen A Mitchell
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

3.  AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

Authors:  C Hiemke; P Baumann; N Bergemann; A Conca; O Dietmaier; K Egberts; M Fric; M Gerlach; C Greiner; G Gründer; E Haen; U Havemann-Reinecke; E Jaquenoud Sirot; H Kirchherr; G Laux; U C Lutz; T Messer; M J Müller; B Pfuhlmann; B Rambeck; P Riederer; B Schoppek; J Stingl; M Uhr; S Ulrich; R Waschgler; G Zernig
Journal:  Pharmacopsychiatry       Date:  2011-09-27       Impact factor: 5.788

4.  Systolic Blood Pressure and Biochemical Assessment of Adherence: A Cross-Sectional Analysis in the Emergency Department.

Authors:  Candace D McNaughton; Nancy J Brown; Russell L Rothman; Dandan Liu; Edmond K Kabagambe; Phillip D Levy; Wesley H Self; Alan B Storrow; Sean P Collins; Christianne L Roumie
Journal:  Hypertension       Date:  2017-06-26       Impact factor: 10.190

5.  US Spending on Personal Health Care and Public Health, 1996-2013.

Authors:  Joseph L Dieleman; Ranju Baral; Maxwell Birger; Anthony L Bui; Anne Bulchis; Abigail Chapin; Hannah Hamavid; Cody Horst; Elizabeth K Johnson; Jonathan Joseph; Rouselle Lavado; Liya Lomsadze; Alex Reynolds; Ellen Squires; Madeline Campbell; Brendan DeCenso; Daniel Dicker; Abraham D Flaxman; Rose Gabert; Tina Highfill; Mohsen Naghavi; Noelle Nightingale; Tara Templin; Martin I Tobias; Theo Vos; Christopher J L Murray
Journal:  JAMA       Date:  2016-12-27       Impact factor: 56.272

6.  Managing Psychotropic Medications in Complex, Real-World Patients Using Comprehensive Therapeutic Drug Monitoring.

Authors:  Jeffrey J Sutherland; Ryan D Morrison; J Scott Daniels; Stephen B Milne; Timothy P Ryan
Journal:  ACS Chem Neurosci       Date:  2017-06-22       Impact factor: 4.418

7.  Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.

Authors:  Dima M Qato; G Caleb Alexander; Rena M Conti; Michael Johnson; Phil Schumm; Stacy Tessler Lindau
Journal:  JAMA       Date:  2008-12-24       Impact factor: 56.272

Review 8.  Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.

Authors:  Jeffrey A Gudin; Shanthi Mogali; Jermaine D Jones; Sandra D Comer
Journal:  Postgrad Med       Date:  2013-07       Impact factor: 3.840

Review 9.  Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.

Authors:  Guillermo Gervasini; Julio Benítez; Juan Antonio Carrillo
Journal:  Eur J Clin Pharmacol       Date:  2010-06-27       Impact factor: 3.064

10.  Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoring.

Authors:  Timothy P Ryan; Ryan D Morrison; Jeffrey J Sutherland; Stephen B Milne; Kendall A Ryan; J Scott Daniels; Anita Misra-Hebert; J Kevin Hicks; Eric Vogan; Kathryn Teng; Thomas M Daly
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

View more
  4 in total

1.  A patient and family reporting system for perceived ambulatory note mistakes: experience at 3 U.S. healthcare centers.

Authors:  Fabienne C Bourgeois; Alan Fossa; Macda Gerard; Marion E Davis; Yhenneko J Taylor; Crystal D Connor; Tracela Vaden; Andrew McWilliams; Melanie D Spencer; Patricia Folcarelli; Sigall K Bell
Journal:  J Am Med Inform Assoc       Date:  2019-12-01       Impact factor: 4.497

2.  Discrepancies in Ophthalmic Medication Documentation for Glaucoma Patients.

Authors:  Jimmy S Chen; Wei-Chun Lin; Joel V Kaluzny; Aiyin Chen; Michael F Chiang; Michelle R Hribar
Journal:  Ophthalmol Sci       Date:  2021-12-13

3.  Bioanalytical Assessment of Plasma Concentrations of Angiotensin-Converting Enzyme II Inhibitors and Angiotensin Receptor Blockers: A Pilot Study Among Patients Hospitalized With Acute Heart Failure.

Authors:  Candace D McNaughton; Sean P Collins; JoAnn Lindenfeld; Ryan Morrison; John Scott Daniels; Thomas J Wang
Journal:  Am J Ther       Date:  2020 Jul/Aug       Impact factor: 3.098

Review 4.  Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics.

Authors:  Martin Schulz; Achim Schmoldt; Hilke Andresen-Streichert; Stefanie Iwersen-Bergmann
Journal:  Crit Care       Date:  2020-05-06       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.